Last Update

2016-09-09T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Dave Amerson?

Dave Amerson

President and Chief Executive Officer

NeoTract Inc

Direct Phone: (925) ***-****       

Email: d***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

NeoTract Inc

4473 Willow Road Suite 100

Pleasanton, California 94588

United States

Company Description

NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. The company's initial focus is on improving the standard of care for patients with BPH using the Ur ... more

Find other employees at this company (125)

Background Information

Employment History

General Manager for the Surgical Urology Division

Coloplast Corp

Affiliations

Board Member
EMKinetics

Board Member
The Urology Society of America

Board Member
American Lithotripsy Society

Education

B.A.

Political Science

University of West Georgia

M.B.A.

Argosy University

Web References (95 Total References)


Dave Amerson - President and ...

urolift.com [cached]

Dave Amerson - President and CEO, NeoTract, Inc.

...
Dave Amerson
Dave is President and CEO of NeoTract, Inc., a medical device company focused on shifting the treatment paradigm in urology. Under his leadership, NeoTract received FDA De Novo clearance for the UroLift® System, a minimally invasive technology to treat symptoms of benign prostatic hyperplasia (BPH). He also led the company to achieve critical reimbursement milestones, including new CPT 1 codes, a New Tech APC code and a national coverage policy by Aetna for the UroLift System. Internationally, NeoTract has achieved positive NICE guidance for the UroLift System in the UK and a prosthesis code with payment for the UroLift implant in Australia.
Dave joined NeoTract in 2011, bringing over 25 years of management experience in the medical device field with an emphasis in urology. Prior to NeoTract, Dave was Global Vice President; General Manager for the Coloplast Surgical Urology division. Dave began his career at Osbon Medical Systems. He is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics. Dave holds an M.B.A. from Argosy University and a B.A. in Political Science from the University of West Georgia.


Dave Amerson - President and ...

urolift.com [cached]

Dave Amerson - President and CEO, NeoTract, Inc.

Dave is President and CEO of NeoTract, Inc., a medical device company focused on shifting the treatment paradigm in urology. Under his leadership, NeoTract received FDA De Novo clearance for the UroLift® System, a minimally invasive technology to treat symptoms of benign prostatic hyperplasia (BPH). He also led the company to achieve critical reimbursement milestones, including new CPT 1 codes, a New Tech APC code and a national coverage policy by Aetna for the UroLift System. Internationally, NeoTract has achieved positive NICE guidance for the UroLift System in the UK and a prosthesis code with payment for the UroLift implant in Australia.
Dave joined NeoTract in 2011, bringing over 25 years of management experience in the medical device field with an emphasis in urology. Prior to NeoTract, Dave was Global Vice President; General Manager for the Coloplast Surgical Urology division. Dave began his career at Osbon Medical Systems. He is a former board member of the Urology Society of America, the American Lithotripsy Society and EMKinetics. Dave holds an M.B.A. from Argosy University and a B.A. in Political Science from the University of West Georgia.


"These excellent clinical results add to ...

urolift.com [cached]

"These excellent clinical results add to the growing body of evidence confirming the benefits of the minimally invasive UroLift implant system as a treatment option for patients suffering from an enlarged prostate, which impacts millions of Americans and often greatly impacts quality of life," said Dave Amerson, president and CEO, NeoTract.


Stated Dave Amerson, ...

urolift.com [cached]

Stated Dave Amerson, President and CEO, NeoTract, Inc.


said Dave Amerson, President ...

urolift.com [cached]

said Dave Amerson, President and CEO, NeoTract.

...
Media Contact: Dave Amerson, President and CEO, +1.925.401.0700

Similar Profiles

Other People with this Name

Other people with the name Amerson

David Amerson
Strategic Industrial Solutions Inc

Austin Amerson
Strategic Industrial Solutions Inc

Asheton Amerson
Anderson Mill Road Baptist Church

Lorrie Amerson
Eastern Virginia Medical School

Lynda Amerson
Myers-Colonial Funeral Home Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory